Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU supports creation of a European cancer research area

19.09.2002


How to build greater coherence in European cancer research? This is the key question to be debated at a conference today, which brings together around 250 representatives from science, the medical profession, government, patient organisations, foundations, industry and European institutions.



The aim of the conference, jointly organised by the European Commission and the European Parliament, is to kick-off the conception of a joint European strategy for cancer research, rallying all actors concerned to improve the coherence and efficiency of their research activities. The conference coincides with the launch, in November 2002, of the EU’s Sixth Research Framework Programme (2002–2006), which has been designed to better structure and integrate the excellent science that Europe already has.

Opening the conference together with the Parliament’s president Pat Cox and Member of Parliament Wim Van Velzen, EU Research Commissioner Philippe Busquin said: “Cancer kills more than 750.000 people a year. The EU is ready to invest up to € 400 million in cancer research over the next 4 years. But our investments will only bear fruit if researchers and funding agencies from across Europe work together with common goals. We need to innovate in the way we organise research at European level. Only then will we be able to quickly translate the phenomenal advances in science into practical and meaningful early stage diagnosis and therapies for patients.”


MEP Wim Van Velzen added: “I am convinced that with a common effort and bundling of initiatives, we can do more and better in Europe. Europe has the potential to combat cancer more effectively. Let’s use it.”

Cancer is still a huge burden on European citizens. Although it is difficult to consolidate figures for Europe , it is known that 240.000 new cases are detected in France each year and that cancer is responsible for 24% of all deaths in the UK.
Considerable resources are devoted to fighting cancer throughout Europe. Yet these efforts are not producing the results that health practitioners and citizens might expect, at a time when basic science is advancing fast in understanding the fundamentals of human life. This is partly due to the fragmentation and duplication of research efforts within Member states and across Europe and the lack of co-ordination at European level.

The EU’s Sixth Framework Programme provides the means to catalyse the realisation of a European cancer research area. Thanks to the active support of Parliament, cancer research is a priority within the health research field for which up to €400 million has been earmarked. Although this represents a relatively modest proportion of the funds spent on cancer research throughout Europe, these resources and the new funding tools of the Framework Programme offer opportunities to co-ordinate research efforts undertaken in publicly and privately funded research institutions, to extend research networks and to tackle common problems.

The EU will support researchers to mount large networks of excellence that bring together the best teams of researchers and clinical practitioners to develop and validate new therapies and interventions. Through integrated projects, sufficient critical mass of expertise and resources can be directed at subjects such as the development of relevant pre-clinical tests to evaluate new therapies or the validation of molecular targets for cancer diagnosis and treatment. Research institutes will be able to attract the world’s leading experts in a certain field through a revamped European scheme for the mobility of researchers. The Commission will also support the co-ordination of national and regional research programmes.

A European strategy for cancer research should also explore how the framework conditions for cancer research in Europe can be improved. One case in point is the organisation of multi-national clinical trials. Commissioner Busquin said: “Europe’s diversity in populations, life-style and disease patterns places us in a unique position to advance the understanding and treatment of cancer. But co-ordination is needed between researchers, hospitals and regional or national authorities to deal with diverging regulatory, ethical and other procedures.”

The conference will enable a broad range of stakeholders in cancer research with an opportunity to present their respective roles and expectations and to make proposals to support the co-operation and co-ordination of cancer research in Europe. The Commission will use the outcome of this consultation to propose a strategy for a European cancer research area.

Stéphane Hogan | alfa

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

Im Focus: Launch of New Industry Working Group for Process Control in Laser Material Processing

At AKL’16, the International Laser Technology Congress held in May this year, interest in the topic of process control was greater than expected. Appropriately, the event was also used to launch the Industry Working Group for Process Control in Laser Material Processing. The group provides a forum for representatives from industry and research to initiate pre-competitive projects and discuss issues such as standards, potential cost savings and feasibility.

In the age of industry 4.0, laser technology is firmly established within manufacturing. A wide variety of laser techniques – from USP ablation and additive...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Laser use for neurosurgery and biofabrication - LaserForum 2016 focuses on medical technology

27.09.2016 | Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

ICPE in Graz for the seventh time

20.09.2016 | Event News

 
Latest News

New switch decides between genome repair and death of cells

27.09.2016 | Life Sciences

Nanotechnology for energy materials: Electrodes like leaf veins

27.09.2016 | Physics and Astronomy

‘Missing link’ found in the development of bioelectronic medicines

27.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>